Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Miller

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|July 5, 2008
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological responseLambert Assoumou, Françoise Brun-Vézinet, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|January 2, 2007
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceRobert W Shafer, Soo-Yon Rhee, Deenan Pillay, et al.
AIDS (London, England)|November 14, 2008
HIV clinical trial design for antiretroviral development: moving forwardKirk M Chan-Tack, Kimberly A Struble, Nathalie Morgensztejn, et al.
Nature Reviews. Gastroenterology & Hepatology|April 15, 2026
Global position statement supporting a World Health Assembly resolution on steatotic liver diseaseJeffrey V Lazarus, Bruno Halpern, Peter E H Schwarz, et al.
Hepatology Communications|May 24, 2021
coreNASH: Multi-stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis TreatmentElizabeth Clearfield, Veronica Miller, Joseph Nadglowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2014
HIV and hepatitis C virus infection in the United States: whom and how to testNivedha Panneer, Erik Lontok, Bernard M Branson, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdlesKelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Hepatitis C virus drug resistance-associated substitutions: State of the art summaryErik Lontok, Patrick Harrington, Anita Howe, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
ReplyVeronica Miller, Patrick Harrington, Anita Howe, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|July 5, 2008
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological responseLambert Assoumou, Françoise Brun-Vézinet, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|January 2, 2007
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceRobert W Shafer, Soo-Yon Rhee, Deenan Pillay, et al.
AIDS (London, England)|November 14, 2008
HIV clinical trial design for antiretroviral development: moving forwardKirk M Chan-Tack, Kimberly A Struble, Nathalie Morgensztejn, et al.
Nature Reviews. Gastroenterology & Hepatology|April 15, 2026
Global position statement supporting a World Health Assembly resolution on steatotic liver diseaseJeffrey V Lazarus, Bruno Halpern, Peter E H Schwarz, et al.
Hepatology Communications|May 24, 2021
coreNASH: Multi-stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis TreatmentElizabeth Clearfield, Veronica Miller, Joseph Nadglowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2014
HIV and hepatitis C virus infection in the United States: whom and how to testNivedha Panneer, Erik Lontok, Bernard M Branson, et al.
Orphanet Journal of Rare Diseases|May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdlesKelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Hepatitis C virus drug resistance-associated substitutions: State of the art summaryErik Lontok, Patrick Harrington, Anita Howe, et al.
Hepatology (Baltimore, Md.)|April 27, 2016
ReplyVeronica Miller, Patrick Harrington, Anita Howe, et al.
Pageof 11